Ironwood Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary

Ironwood Pharmaceuticals

04/05/2023 14:33

* Ironwood Pharmaceuticals Inc  IRWD.OQ  reported quarterly
adjusted earnings of 25 cents​​ per share for the quarter ended
in March. The mean expectation of four analysts for the quarter
was for earnings of 24 cents per share.
    * Revenue rose 6.7% to $104.06 million from a year ago;
analysts
expected $100.41 million. 
    * Ironwood Pharmaceuticals Inc's reported EPS for the
quarter was
25 cents​.
    * The mean earnings estimate of analysts had risen by
about 1% in
the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate 
    * Ironwood Pharmaceuticals Inc shares had fallen by 0.1%
this
quarter and lost 15.2% so far this year.
    * The company reported quarterly net income of $45.71
million.
    * Wall Street's median 12-month price target for Ironwood
Pharmaceuticals Inc is $13.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
4 at 01:33 p.m. UTC. ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      0.24           0.25           Beat
 Dec. 31 2022      0.27           0.27           Met
 Sep. 30 2022      0.27           0.28           Beat
 Jun. 30 2022      0.30           0.21           Missed